Literature DB >> 2441998

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction.

S Qin, S Cobbold, H Tighe, R Benjamin, H Waldmann.   

Abstract

A pair of rat anti-mouse CD4 monoclonal antibodies (mAb) have been selected which bind to different epitopes of the molecule. Both the mAb are rat IgG2b and show clear synergistic activity in complement lysis in vitro. When injected together in vivo, they exhibit an improved immunosuppressive effect, compared to each antibody alone, on allogeneic graft rejection, humoral responses and on tolerance induction. Limiting dilution analysis indicates that the in vivo depletion of interleukin 2-producing cells is improved using both mAb by 2-3-fold over that obtained with the individual antibodies. As little as 60 ng per mouse of the CD4 antibody pair was sufficient to allow the induction of tolerance to human gamma-globulin, even without elimination of the CD4+ cells. The results suggest that appropriate antibody pairs may be good candidates for effective immunosuppressive serotherapy in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441998     DOI: 10.1002/eji.1830170813

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  Prediction of graft prolongation by mixed lymphocyte culture following anti-CD4 monoclonal antibody treatment among different donor-recipient combinations.

Authors:  K Hamano; H Ito; B Shirasawa; H Gohra; T Katoh; Y Fujimura; K Esato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody.

Authors:  G Shen; H Zhu; X Wang; Y Zhang; Z Zhu; S Wang
Journal:  J Tongji Med Univ       Date:  1999

Review 4.  Mechanisms of transplantation immunity.

Authors:  E Simpson
Journal:  Springer Semin Immunopathol       Date:  1992

5.  Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor.

Authors:  Despina Voulgaraki; Rita Mitnacht-Kraus; Michelle Letarte; Mildred Foster-Cuevas; Marion H Brown; A Neil Barclay
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

6.  Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Authors:  Chee M Ng; Eric Stefanich; Banmeet S Anand; Paul J Fielder; Louis Vaickus
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

7.  Mutants of cultured mouse cells deficient in Ly-2 antigen.

Authors:  D Iannelli; R Palomba; R Capparelli; F Scala; A Iannelli; L Ferrara; T Uchida
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 8.  Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

Authors:  R O Williams
Journal:  Springer Semin Immunopathol       Date:  1998

9.  Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.

Authors:  O Utermöhlen; C Schulze-Garg; G Warnecke; R Gugel; J Löhler; W Deppert
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.

Authors:  R O Williams; J Ghrayeb; M Feldmann; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.